Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Florida divided over genetically modified mosquitoes
Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses.
Referendum reveals concerns over planned release

Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses, according to the Centre for Infectious Disease Research and Policy.

The Centre say that, in a non-binding referendum, 58 per cent of voters in Monroe County voted in favour of using the mosquitoes. Meanwhile in Key Haven - a neighbourhood where the insects would be released next spring - 65 per cent of voters opposed the idea.

In spite of the need for mosquito control, locals worry that genetically modified mosquitoes may pose an unpredicted environmental threat. It is thought that early reports, which erroneously linked microcephaly to genetically modified mosquitoes, may also have a part to play in the doubt.

The genetically modified mosquitoes are manufactured by British company Oxitec, who plan to assess their effectiveness for fighting Zika.  According to BBC News, Oxitec want to release male insects across a 17-hectare region of Key Haven, a small suburb located on an island on Florida’s southern tip.

The US Food & Drug administration approved Oxitec’s mosquitoes for use in August, saying that, following months of comments from the public, the mosquitos fell under the category of Finding of No Significant Impact (FONSI).

The results of the Florida poll will now be put to board members on 19 November, who will make the final decision on whether the mosquitoes will be used next spring.

Speaking to BBC News, Dr Derric Nimmo, who has been leading Oxitec’s proposed trial in Key Haven, said: We've had six years of releases, involving millions of male mosquitoes, and there have been no reports of any adverse effects."

"It's important we're as transparent as possible... we've been trying to give people the facts and information so they can make an informed choice."

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.